1VIN | A:181-308; A:309-432 | BOVINE CYCLIN A3 |
2G9X | B:171-309; B:310-432; D:171-309; D:310-432 | STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271 |
3BHT | B:171-308; B:309-432; D:171-308; D:309-432 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3 |
3BHU | B:171-308; B:309-432; D:171-308; D:309-432 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5 |
3BHV | B:171-308; B:309-432; D:171-308; D:309-432 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B |
3DDP | B:171-309; B:310-432; D:171-309; D:310-438 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8 |
3DDQ | B:171-309; B:310-432; D:171-309; D:310-439 | STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE |
3DOG | B:171-309; B:310-432; D:171-309; D:310-434 | STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1 |
3MY5 | B:171-308; D:171-308; D:309-432; B:309-432 | CDK2/CYCLINA IN COMPLEX WITH DRB |